"Ocular surface squamous neoplasia – Review of etio-pathogenesis and an update on clinico-pathological diagnosis". Saudi Journal of Ophthalmology27 (3): 177–86. July 2013. doi:10.1016/j.sjopt.2013.07.002. PMC3770226. PMID24227983.
"Chronic diarrhea and AIDS: insights into studies with non-human primates". Current HIV Research3 (3): 199–205. July 2005. doi:10.2174/1570162054368084. PMID16022653.
Coovadia H (2004). "Antiretroviral agents—how best to protect infants from HIV and save their mothers from AIDS". N. Engl. J. Med.351 (3): 289–292. doi:10.1056/NEJMe048128. PMID15247337.
"An overview of the relative risks of different sexual behaviours on HIV transmission.". Current Opinion in HIV and AIDS5 (4): 291–7. July 2010. doi:10.1097/COH.0b013e32833a88a3. PMID20543603.
"Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies.". The Lancet Infectious Diseases9 (2): 118–29. February 2009. doi:10.1016/S1473-3099(09)70021-0. PMC4467783. PMID19179227.
"Systematic review of orogenital HIV-1 transmission probabilities.". International Journal of Epidemiology37 (6): 1255–65. December 2008. doi:10.1093/ije/dyn151. PMC2638872. PMID18664564.
LeMessurier, J; Traversy, G; Varsaneux, O; Weekes, M; Avey, MT; Niragira, O; Gervais, R; Guyatt, G et al. (November 19, 2018). "Risk of sexual transmission of human immunodeficiency virus with antiretroviral therapy, suppressed viral load and condom use: a systematic review". Canadian Medical Association Journal190 (46): E1350–E1360. doi:10.1503/cmaj.180311. PMC6239917. PMID30455270.
"Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies". The Lancet. Infectious Diseases9 (2): 118–29. February 2009. doi:10.1016/S1473-3099(09)70021-0. PMC4467783. PMID19179227.
"Nonoccupational postexposure prophylaxis following sexual assault in industrialized low-HIV-prevalence countries: a review". Psychology, Health & Medicine17 (2): 235–54. 2012. doi:10.1080/13548506.2011.579984. PMID22372741.
"Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis". AIDS20 (6): 805–12. April 2006. doi:10.1097/01.aids.0000218543.46963.6d. PMID16549963.
"Prevention of vertical transmission of HIV-1 in resource-limited settings". Expert Review of Anti-Infective Therapy8 (10): 1163–75. October 2010. doi:10.1586/eri.10.94. PMID20954881.
"Antiretroviral interventions for preventing breast milk transmission of HIV". The Cochrane Database of Systematic Reviews10 (10): CD011323. October 2014. doi:10.1002/14651858.CD011323. PMID25280769.
"Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS". The Journal of General Virology84 (Pt 7): 1649–61. July 2003. doi:10.1099/vir.0.19110-0. PMID12810858.
"Following the path of the virus: the exploitation of host DNA repair mechanisms by retroviruses". ACS Chemical Biology1 (4): 217–26. May 2006. doi:10.1021/cb600131q. PMID17163676.
"Avoiding the void: cell-to-cell spread of human viruses". Nature Reviews. Microbiology6 (11): 815–26. November 2008. doi:10.1038/nrmicro1972. PMID18923409.
"Comparison of HIV-1 and HIV-2 infectivity from a prospective cohort study in Senegal". Statistics in Medicine22 (4): 573–93. February 2003. doi:10.1002/sim.1342. PMID12590415.
"Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract". The Journal of Experimental Medicine200 (6): 761–70. September 2004. doi:10.1084/jem.20041196. PMC2211967. PMID15365095.
"CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract". The Journal of Experimental Medicine200 (6): 749–59. September 2004. doi:10.1084/jem.20040874. PMC2211962. PMID15365096.
"Immune activation and inflammation in HIV-1 infection: causes and consequences". The Journal of Pathology214 (2): 231–41. January 2008. doi:10.1002/path.2276. PMID18161758.
"Microbial translocation is a cause of systemic immune activation in chronic HIV infection". Nature Medicine12 (12): 1365–71. December 2006. doi:10.1038/nm1511. PMC1717013. PMID17115046.
US Preventive Services Task, Force.; Owens, DK; Davidson, KW; Krist, AH; Barry, MJ; Cabana, M; Caughey, AB; Curry, SJ et al. (18 June 2019). "Screening for HIV Infection: US Preventive Services Task Force Recommendation Statement.". JAMA321 (23): 2326–2336. doi:10.1001/jama.2019.6587. PMID31184701.
"A review of the effectiveness and acceptability of the female condom for dual protection". Sexual Health9 (1): 18–26. March 2012. doi:10.1071/SH11037. PMID22348629.
"Spermicides, microbicides and antiviral agents: recent advances in the development of novel multi-functional compounds". Mini Reviews in Medicinal Chemistry9 (13): 1556–67. November 2009. doi:10.2174/138955709790361548. PMID20205637.
Siegfried, Nandi, ed (April 2009). "Male circumcision for prevention of heterosexual acquisition of HIV in men". The Cochrane Database of Systematic Reviews (2): CD003362. doi:10.1002/14651858.CD003362.pub2. PMID19370585.
"Behavioral aspects of male circumcision for the prevention of HIV infection". Current HIV/AIDS Reports6 (4): 187–93. November 2009. doi:10.1007/s11904-009-0025-9. PMC3557929. PMID19849961.(subscription required)
"Male circumcision to reduce the risk of HIV and sexually transmitted infections among men who have sex with men". Current Opinion in Infectious Diseases23 (1): 45–52. February 2010. doi:10.1097/QCO.0b013e328334e54d. PMID19935420.
Wiysonge, Charles Shey, ed (June 2011). "Male circumcision for prevention of homosexual acquisition of HIV in men". The Cochrane Database of Systematic Reviews (6): CD007496. doi:10.1002/14651858.CD007496.pub2. PMID21678366.
"HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society–USA Panel". JAMA312 (4): 390–409. July 23–30, 2014. doi:10.1001/jama.2014.7999. PMC6309682. PMID25038358.
"Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies". Current HIV/AIDS Reports4 (4): 165–72. December 2007. doi:10.1007/s11904-007-0024-7. PMC2937204. PMID18366947.
"Effectiveness of peer education interventions for HIV prevention, adolescent pregnancy prevention and sexual health promotion for young people: a systematic review of European studies". Health Education Research27 (5): 904–13. October 2012. doi:10.1093/her/cys055. PMID22641791.
"Voluntary counseling and testing (VCT) for changing HIV-related risk behavior in developing countries". The Cochrane Database of Systematic Reviews9 (9): CD001224. September 2012. doi:10.1002/14651858.CD001224.pub4. PMC3931252. PMID22972050.
Lopez, LM; Grey, TW; Chen, M; Denison, J; Stuart, G (9 August 2016). "Behavioral interventions for improving contraceptive use among women living with HIV.". The Cochrane Database of Systematic Reviews (8): CD010243. doi:10.1002/14651858.CD010243.pub3. PMID27505053.
"Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples". The Cochrane Database of Systematic Reviews4 (4): CD009153. April 2013. doi:10.1002/14651858.CD009153.pub3. PMC4026368. PMID23633367.
Owens, Douglas K.; Davidson, Karina W.; Krist, Alex H.; Barry, Michael J.; Cabana, Michael; Caughey, Aaron B.; Curry, Susan J.; Doubeni, Chyke A. et al. (11 June 2019). "Preexposure Prophylaxis for the Prevention of HIV Infection". JAMA321 (22): 2203–2213. doi:10.1001/jama.2019.6390. PMID31184747.
"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial". The Lancet381 (9883): 2083–90. June 2013. doi:10.1016/S0140-6736(13)61127-7. PMID23769234.
US Preventive Services Task, Force.; Owens, DK; Davidson, KW; Krist, AH; Barry, MJ; Cabana, M; Caughey, AB; Curry, SJ et al. (11 June 2019). "Preexposure Prophylaxis for the Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statement.". JAMA321 (22): 2203–2213. doi:10.1001/jama.2019.6390. PMID31184747.
"Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis". BMJ345 (oct03 3): e5945. October 2012. doi:10.1136/bmj.e5945. PMC3489107. PMID23038795.
Young, Taryn, ed (January 2007). "Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure". The Cochrane Database of Systematic Reviews (1): CD002835. doi:10.1002/14651858.CD002835.pub3. PMID17253483.
Siegfried, Nandi, ed (July 2011). "Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection". The Cochrane Database of Systematic Reviews (7): CD003510. doi:10.1002/14651858.CD003510.pub3. PMID21735394.
Horvath, Tara, ed (January 2009). "Interventions for preventing late postnatal mother-to-child transmission of HIV". The Cochrane Database of Systematic Reviews (1): CD006734. doi:10.1002/14651858.CD006734.pub2. PMID19160297.
"Life expectancy of HIV-positive adults: a review". Sexual Health8 (4): 526–33. December 2011. doi:10.1071/SH11046. PMID22127039.
"Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies". The Lancet373 (9672): 1352–63. April 2009. doi:10.1016/S0140-6736(09)60612-7. PMC2670965. PMID19361855.
"Economic and quality of life outcomes of antiretroviral therapy for HIV/AIDS in developing countries: a systematic literature review". AIDS Care21 (11): 1343–56. November 2009. doi:10.1080/09540120902889926. PMID20024710.
"Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review". Addiction103 (8): 1242–57. August 2008. doi:10.1111/j.1360-0443.2008.02269.x. PMID18855813.
"Influenza vaccination for immunocompromised patients: summary of a systematic review and meta-analysis". Influenza and Other Respiratory Viruses7 Suppl 2: 72–75. September 2013. doi:10.1111/irv.12084. PMC5909396. PMID24034488.
"Efficacy and safety of zinc supplementation for adults, children and pregnant women with HIV infection: systematic review". Tropical Medicine & International Health16 (12): 1474–82. December 2011. doi:10.1111/j.1365-3156.2011.02871.x. PMID21895892.
"Micronutrient supplementation in pregnant women with HIV infection". The Cochrane Database of Systematic Reviews (3): CD009755. March 2012. doi:10.1002/14651858.CD009755. PMID22419344.
"Micronutrient supplementation for children with HIV infection". The Cochrane Database of Systematic Reviews (10): CD010666. October 2013. doi:10.1002/14651858.CD010666. PMID24114375.
"Complementary therapies for the treatment of HIV: in search of the evidence". International Journal of STD & AIDS16 (6): 395–403. June 2005. doi:10.1258/0956462054093962. PMID15969772.
"Complementary and alternative medicine use among HIV-positive people: research synthesis and implications for HIV care". AIDS Care20 (8): 1002–18. September 2008. doi:10.1080/09540120701767216. PMC2570227. PMID18608078.
Liu, Jian Ping, ed (July 2005). "Herbal medicines for treating HIV infection and AIDS". The Cochrane Database of Systematic Reviews (3): CD003937. doi:10.1002/14651858.CD003937.pub2. PMID16034917.
"The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS". The Cochrane Database of Systematic Reviews4 (4): CD005175. April 2013. doi:10.1002/14651858.CD005175.pub3. PMID23633327.
"Current status of HIV infection: a review for non-HIV-treating physicians". International Journal of Dermatology46 (12): 1219–28. December 2007. doi:10.1111/j.1365-4632.2007.03520.x. PMID18173512.
"AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy". The Oncologist10 (6): 412–26. Jun–Jul 2005. doi:10.1634/theoncologist.10-6-412. PMID15967835.
"The impact of host genetics on HIV infection and disease progression in the era of highly active antiretroviral therapy". AIDS17 Suppl 4 (Suppl 4): S51–60. 2003. doi:10.1097/00002030-200317004-00006. PMID15080180.
"AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection". The Journal of Infection48 (1): 1–12. January 2004. doi:10.1016/j.jinf.2003.09.001. PMID14667787.
"The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis". The Journal of Biological Chemistry279 (46): 48197–204. November 2004. doi:10.1074/jbc.M406195200. PMID15331610.
"The C terminus of HIV-1 Tat modulates the extent of CD178-mediated apoptosis of T cells". The Journal of Biological Chemistry280 (46): 38376–82. November 2005. doi:10.1074/jbc.M506630200. PMID16155003.
"Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review". AIDS20 (17): 2165–74. November 2006. doi:10.1097/QAD.0b013e32801022eb. PMID17086056.
"The spread, treatment, and prevention of HIV-1: evolution of a global pandemic". The Journal of Clinical Investigation118 (4): 1244–54. April 2008. doi:10.1172/JCI34706. PMC2276790. PMID18382737.
"Retrotransposons revisited: the restraint and rehabilitation of parasites". Cell135 (1): 23–35. October 2008. doi:10.1016/j.cell.2008.09.022. PMID18854152.(subscription required)
"The origins of acquired immune deficiency syndrome viruses: where and when?". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences356 (1410): 867–76. June 2001. doi:10.1098/rstb.2001.0863. PMC1088480. PMID11405934.
"Serial human passage of simian immunodeficiency virus by unsterile injections and the emergence of epidemic human immunodeficiency virus in Africa". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences356 (1410): 911–20. June 2001. doi:10.1098/rstb.2001.0867. PMC1088484. PMID11405938.
"Punished for their good deeds: stigmatization for AIDS volunteers". American Behavioral Scientist42 (7): 1175–92. 1999. doi:10.1177/0002764299042007009.
"HIV-related stigma and knowledge in the United States: prevalence and trends, 1991–1999". American Journal of Public Health92 (3): 371–77. March 2002. doi:10.2105/AJPH.92.3.371. PMC1447082. PMID11867313.
"Interventions for improving employment outcomes for workers with HIV". The Cochrane Database of Systematic Reviews5 (5): CD010090. May 2015. doi:10.1002/14651858.CD010090.pub2. PMID26022149.
"Sex and HIV education programs: their impact on sexual behaviors of young people throughout the world". The Journal of Adolescent Health40 (3): 206–17. March 2007. doi:10.1016/j.jadohealth.2006.11.143. PMID17321420.
"Complications of HIV infection: a systems-based approach". American Family Physician83 (4): 395–406. February 2011. PMID21322514.
"Ocular surface squamous neoplasia – Review of etio-pathogenesis and an update on clinico-pathological diagnosis". Saudi Journal of Ophthalmology27 (3): 177–86. July 2013. doi:10.1016/j.sjopt.2013.07.002. PMC3770226. PMID24227983.
"Chronic diarrhea and AIDS: insights into studies with non-human primates". Current HIV Research3 (3): 199–205. July 2005. doi:10.2174/1570162054368084. PMID16022653.
"Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services.". MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control54 (RR-2): 1–20. 21 January 2005. PMID15660015.
Coovadia H (2004). "Antiretroviral agents—how best to protect infants from HIV and save their mothers from AIDS". N. Engl. J. Med.351 (3): 289–292. doi:10.1056/NEJMe048128. PMID15247337.
Kripke C (1 August 2007). "Antiretroviral prophylaxis for occupational exposure to HIV.". American Family Physician76 (3): 375–6. PMID17708137.
"An overview of the relative risks of different sexual behaviours on HIV transmission.". Current Opinion in HIV and AIDS5 (4): 291–7. July 2010. doi:10.1097/COH.0b013e32833a88a3. PMID20543603.
"Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies.". The Lancet Infectious Diseases9 (2): 118–29. February 2009. doi:10.1016/S1473-3099(09)70021-0. PMC4467783. PMID19179227.
"Systematic review of orogenital HIV-1 transmission probabilities.". International Journal of Epidemiology37 (6): 1255–65. December 2008. doi:10.1093/ije/dyn151. PMC2638872. PMID18664564.
"Antiretroviral prophylaxis for occupational exposure to HIV". American Family Physician76 (3): 375–76. August 2007. PMID17708137.
LeMessurier, J; Traversy, G; Varsaneux, O; Weekes, M; Avey, MT; Niragira, O; Gervais, R; Guyatt, G et al. (November 19, 2018). "Risk of sexual transmission of human immunodeficiency virus with antiretroviral therapy, suppressed viral load and condom use: a systematic review". Canadian Medical Association Journal190 (46): E1350–E1360. doi:10.1503/cmaj.180311. PMC6239917. PMID30455270.
"Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies". The Lancet. Infectious Diseases9 (2): 118–29. February 2009. doi:10.1016/S1473-3099(09)70021-0. PMC4467783. PMID19179227.
"Nonoccupational postexposure prophylaxis following sexual assault in industrialized low-HIV-prevalence countries: a review". Psychology, Health & Medicine17 (2): 235–54. 2012. doi:10.1080/13548506.2011.579984. PMID22372741.
"Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis". AIDS20 (6): 805–12. April 2006. doi:10.1097/01.aids.0000218543.46963.6d. PMID16549963.
Centers for Disease Control Prevention (CDC) (October 2010). "HIV transmission through transfusion – Missouri and Colorado, 2008". Morbidity and Mortality Weekly Report59 (41): 1335–39. PMID20966896.
"Prevention of vertical transmission of HIV-1 in resource-limited settings". Expert Review of Anti-Infective Therapy8 (10): 1163–75. October 2010. doi:10.1586/eri.10.94. PMID20954881.
"Antiretroviral interventions for preventing breast milk transmission of HIV". The Cochrane Database of Systematic Reviews10 (10): CD011323. October 2014. doi:10.1002/14651858.CD011323. PMID25280769.
"Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS". The Journal of General Virology84 (Pt 7): 1649–61. July 2003. doi:10.1099/vir.0.19110-0. PMID12810858.
International Committee on Taxonomy of Viruses61. Retroviridae. National Institutes of Health (2002).
"Following the path of the virus: the exploitation of host DNA repair mechanisms by retroviruses". ACS Chemical Biology1 (4): 217–26. May 2006. doi:10.1021/cb600131q. PMID17163676.
"Avoiding the void: cell-to-cell spread of human viruses". Nature Reviews. Microbiology6 (11): 815–26. November 2008. doi:10.1038/nrmicro1972. PMID18923409.
"Comparison of HIV-1 and HIV-2 infectivity from a prospective cohort study in Senegal". Statistics in Medicine22 (4): 573–93. February 2003. doi:10.1002/sim.1342. PMID12590415.
"Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract". The Journal of Experimental Medicine200 (6): 761–70. September 2004. doi:10.1084/jem.20041196. PMC2211967. PMID15365095.
"CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract". The Journal of Experimental Medicine200 (6): 749–59. September 2004. doi:10.1084/jem.20040874. PMC2211962. PMID15365096.
"Immune activation and inflammation in HIV-1 infection: causes and consequences". The Journal of Pathology214 (2): 231–41. January 2008. doi:10.1002/path.2276. PMID18161758.
"Microbial translocation is a cause of systemic immune activation in chronic HIV infection". Nature Medicine12 (12): 1365–71. December 2006. doi:10.1038/nm1511. PMC1717013. PMID17115046.
US Preventive Services Task, Force.; Owens, DK; Davidson, KW; Krist, AH; Barry, MJ; Cabana, M; Caughey, AB; Curry, SJ et al. (18 June 2019). "Screening for HIV Infection: US Preventive Services Task Force Recommendation Statement.". JAMA321 (23): 2326–2336. doi:10.1001/jama.2019.6587. PMID31184701.
"Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years – United States, 2008". MMWR. Recommendations and Reports57 (RR-10): 1–12. December 2008. PMID19052530.
"A review of the effectiveness and acceptability of the female condom for dual protection". Sexual Health9 (1): 18–26. March 2012. doi:10.1071/SH11037. PMID22348629.
"Spermicides, microbicides and antiviral agents: recent advances in the development of novel multi-functional compounds". Mini Reviews in Medicinal Chemistry9 (13): 1556–67. November 2009. doi:10.2174/138955709790361548. PMID20205637.
Siegfried, Nandi, ed (April 2009). "Male circumcision for prevention of heterosexual acquisition of HIV in men". The Cochrane Database of Systematic Reviews (2): CD003362. doi:10.1002/14651858.CD003362.pub2. PMID19370585.
"Behavioral aspects of male circumcision for the prevention of HIV infection". Current HIV/AIDS Reports6 (4): 187–93. November 2009. doi:10.1007/s11904-009-0025-9. PMC3557929. PMID19849961.(subscription required)
"Male circumcision to reduce the risk of HIV and sexually transmitted infections among men who have sex with men". Current Opinion in Infectious Diseases23 (1): 45–52. February 2010. doi:10.1097/QCO.0b013e328334e54d. PMID19935420.
Wiysonge, Charles Shey, ed (June 2011). "Male circumcision for prevention of homosexual acquisition of HIV in men". The Cochrane Database of Systematic Reviews (6): CD007496. doi:10.1002/14651858.CD007496.pub2. PMID21678366.
"HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society–USA Panel". JAMA312 (4): 390–409. July 23–30, 2014. doi:10.1001/jama.2014.7999. PMC6309682. PMID25038358.
"Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies". Current HIV/AIDS Reports4 (4): 165–72. December 2007. doi:10.1007/s11904-007-0024-7. PMC2937204. PMID18366947.
"Effectiveness of peer education interventions for HIV prevention, adolescent pregnancy prevention and sexual health promotion for young people: a systematic review of European studies". Health Education Research27 (5): 904–13. October 2012. doi:10.1093/her/cys055. PMID22641791.
"Voluntary counseling and testing (VCT) for changing HIV-related risk behavior in developing countries". The Cochrane Database of Systematic Reviews9 (9): CD001224. September 2012. doi:10.1002/14651858.CD001224.pub4. PMC3931252. PMID22972050.
Lopez, LM; Grey, TW; Chen, M; Denison, J; Stuart, G (9 August 2016). "Behavioral interventions for improving contraceptive use among women living with HIV.". The Cochrane Database of Systematic Reviews (8): CD010243. doi:10.1002/14651858.CD010243.pub3. PMID27505053.
"Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples". The Cochrane Database of Systematic Reviews4 (4): CD009153. April 2013. doi:10.1002/14651858.CD009153.pub3. PMC4026368. PMID23633367.
Owens, Douglas K.; Davidson, Karina W.; Krist, Alex H.; Barry, Michael J.; Cabana, Michael; Caughey, Aaron B.; Curry, Susan J.; Doubeni, Chyke A. et al. (11 June 2019). "Preexposure Prophylaxis for the Prevention of HIV Infection". JAMA321 (22): 2203–2213. doi:10.1001/jama.2019.6390. PMID31184747.
"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial". The Lancet381 (9883): 2083–90. June 2013. doi:10.1016/S0140-6736(13)61127-7. PMID23769234.
US Preventive Services Task, Force.; Owens, DK; Davidson, KW; Krist, AH; Barry, MJ; Cabana, M; Caughey, AB; Curry, SJ et al. (11 June 2019). "Preexposure Prophylaxis for the Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statement.". JAMA321 (22): 2203–2213. doi:10.1001/jama.2019.6390. PMID31184747.
"Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis". BMJ345 (oct03 3): e5945. October 2012. doi:10.1136/bmj.e5945. PMC3489107. PMID23038795.
"HIV exposure through contact with body fluids". Prescrire International21 (126): 100–01, 103–05. April 2012. PMID22515138.
Young, Taryn, ed (January 2007). "Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure". The Cochrane Database of Systematic Reviews (1): CD002835. doi:10.1002/14651858.CD002835.pub3. PMID17253483.
Siegfried, Nandi, ed (July 2011). "Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection". The Cochrane Database of Systematic Reviews (7): CD003510. doi:10.1002/14651858.CD003510.pub3. PMID21735394.
Horvath, Tara, ed (January 2009). "Interventions for preventing late postnatal mother-to-child transmission of HIV". The Cochrane Database of Systematic Reviews (1): CD006734. doi:10.1002/14651858.CD006734.pub2. PMID19160297.
"Life expectancy of HIV-positive adults: a review". Sexual Health8 (4): 526–33. December 2011. doi:10.1071/SH11046. PMID22127039.
"Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies". The Lancet373 (9672): 1352–63. April 2009. doi:10.1016/S0140-6736(09)60612-7. PMC2670965. PMID19361855.
"Economic and quality of life outcomes of antiretroviral therapy for HIV/AIDS in developing countries: a systematic literature review". AIDS Care21 (11): 1343–56. November 2009. doi:10.1080/09540120902889926. PMID20024710.
"Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review". Addiction103 (8): 1242–57. August 2008. doi:10.1111/j.1360-0443.2008.02269.x. PMID18855813.
"Adverse effects of antiretroviral therapy for HIV infection". Canadian Medical Association Journal170 (2): 229–38. January 2004. PMC315530. PMID14734438.
"Influenza vaccination for immunocompromised patients: summary of a systematic review and meta-analysis". Influenza and Other Respiratory Viruses7 Suppl 2: 72–75. September 2013. doi:10.1111/irv.12084. PMC5909396. PMID24034488.
"Efficacy and safety of zinc supplementation for adults, children and pregnant women with HIV infection: systematic review". Tropical Medicine & International Health16 (12): 1474–82. December 2011. doi:10.1111/j.1365-3156.2011.02871.x. PMID21895892.
"Micronutrient supplementation in pregnant women with HIV infection". The Cochrane Database of Systematic Reviews (3): CD009755. March 2012. doi:10.1002/14651858.CD009755. PMID22419344.
"Micronutrient supplementation for children with HIV infection". The Cochrane Database of Systematic Reviews (10): CD010666. October 2013. doi:10.1002/14651858.CD010666. PMID24114375.
"Complementary therapies for the treatment of HIV: in search of the evidence". International Journal of STD & AIDS16 (6): 395–403. June 2005. doi:10.1258/0956462054093962. PMID15969772.
"Complementary and alternative medicine use among HIV-positive people: research synthesis and implications for HIV care". AIDS Care20 (8): 1002–18. September 2008. doi:10.1080/09540120701767216. PMC2570227. PMID18608078.
Liu, Jian Ping, ed (July 2005). "Herbal medicines for treating HIV infection and AIDS". The Cochrane Database of Systematic Reviews (3): CD003937. doi:10.1002/14651858.CD003937.pub2. PMID16034917.
"The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS". The Cochrane Database of Systematic Reviews4 (4): CD005175. April 2013. doi:10.1002/14651858.CD005175.pub3. PMID23633327.
"Current status of HIV infection: a review for non-HIV-treating physicians". International Journal of Dermatology46 (12): 1219–28. December 2007. doi:10.1111/j.1365-4632.2007.03520.x. PMID18173512.
"AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy". The Oncologist10 (6): 412–26. Jun–Jul 2005. doi:10.1634/theoncologist.10-6-412. PMID15967835.
"The impact of host genetics on HIV infection and disease progression in the era of highly active antiretroviral therapy". AIDS17 Suppl 4 (Suppl 4): S51–60. 2003. doi:10.1097/00002030-200317004-00006. PMID15080180.
"AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection". The Journal of Infection48 (1): 1–12. January 2004. doi:10.1016/j.jinf.2003.09.001. PMID14667787.
"The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis". The Journal of Biological Chemistry279 (46): 48197–204. November 2004. doi:10.1074/jbc.M406195200. PMID15331610.
"The C terminus of HIV-1 Tat modulates the extent of CD178-mediated apoptosis of T cells". The Journal of Biological Chemistry280 (46): 38376–82. November 2005. doi:10.1074/jbc.M506630200. PMID16155003.
"Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review". AIDS20 (17): 2165–74. November 2006. doi:10.1097/QAD.0b013e32801022eb. PMID17086056.
"The spread, treatment, and prevention of HIV-1: evolution of a global pandemic". The Journal of Clinical Investigation118 (4): 1244–54. April 2008. doi:10.1172/JCI34706. PMC2276790. PMID18382737.
"Retrotransposons revisited: the restraint and rehabilitation of parasites". Cell135 (1): 23–35. October 2008. doi:10.1016/j.cell.2008.09.022. PMID18854152.(subscription required)
"The origins of acquired immune deficiency syndrome viruses: where and when?". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences356 (1410): 867–76. June 2001. doi:10.1098/rstb.2001.0863. PMC1088480. PMID11405934.
"Serial human passage of simian immunodeficiency virus by unsterile injections and the emergence of epidemic human immunodeficiency virus in Africa". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences356 (1410): 911–20. June 2001. doi:10.1098/rstb.2001.0867. PMC1088484. PMID11405938.
"HIV-related stigma and knowledge in the United States: prevalence and trends, 1991–1999". American Journal of Public Health92 (3): 371–77. March 2002. doi:10.2105/AJPH.92.3.371. PMC1447082. PMID11867313.
"Interventions for improving employment outcomes for workers with HIV". The Cochrane Database of Systematic Reviews5 (5): CD010090. May 2015. doi:10.1002/14651858.CD010090.pub2. PMID26022149.
"Sex and HIV education programs: their impact on sexual behaviors of young people throughout the world". The Journal of Adolescent Health40 (3): 206–17. March 2007. doi:10.1016/j.jadohealth.2006.11.143. PMID17321420.
"Ocular surface squamous neoplasia – Review of etio-pathogenesis and an update on clinico-pathological diagnosis". Saudi Journal of Ophthalmology27 (3): 177–86. July 2013. doi:10.1016/j.sjopt.2013.07.002. PMC3770226. PMID24227983.
"Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies.". The Lancet Infectious Diseases9 (2): 118–29. February 2009. doi:10.1016/S1473-3099(09)70021-0. PMC4467783. PMID19179227.
"Systematic review of orogenital HIV-1 transmission probabilities.". International Journal of Epidemiology37 (6): 1255–65. December 2008. doi:10.1093/ije/dyn151. PMC2638872. PMID18664564.
LeMessurier, J; Traversy, G; Varsaneux, O; Weekes, M; Avey, MT; Niragira, O; Gervais, R; Guyatt, G et al. (November 19, 2018). "Risk of sexual transmission of human immunodeficiency virus with antiretroviral therapy, suppressed viral load and condom use: a systematic review". Canadian Medical Association Journal190 (46): E1350–E1360. doi:10.1503/cmaj.180311. PMC6239917. PMID30455270.
"Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies". The Lancet. Infectious Diseases9 (2): 118–29. February 2009. doi:10.1016/S1473-3099(09)70021-0. PMC4467783. PMID19179227.
"Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract". The Journal of Experimental Medicine200 (6): 761–70. September 2004. doi:10.1084/jem.20041196. PMC2211967. PMID15365095.
"CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract". The Journal of Experimental Medicine200 (6): 749–59. September 2004. doi:10.1084/jem.20040874. PMC2211962. PMID15365096.
"Microbial translocation is a cause of systemic immune activation in chronic HIV infection". Nature Medicine12 (12): 1365–71. December 2006. doi:10.1038/nm1511. PMC1717013. PMID17115046.
"Behavioral aspects of male circumcision for the prevention of HIV infection". Current HIV/AIDS Reports6 (4): 187–93. November 2009. doi:10.1007/s11904-009-0025-9. PMC3557929. PMID19849961.(subscription required)
"HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society–USA Panel". JAMA312 (4): 390–409. July 23–30, 2014. doi:10.1001/jama.2014.7999. PMC6309682. PMID25038358.
"Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies". Current HIV/AIDS Reports4 (4): 165–72. December 2007. doi:10.1007/s11904-007-0024-7. PMC2937204. PMID18366947.
"Voluntary counseling and testing (VCT) for changing HIV-related risk behavior in developing countries". The Cochrane Database of Systematic Reviews9 (9): CD001224. September 2012. doi:10.1002/14651858.CD001224.pub4. PMC3931252. PMID22972050.
"Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples". The Cochrane Database of Systematic Reviews4 (4): CD009153. April 2013. doi:10.1002/14651858.CD009153.pub3. PMC4026368. PMID23633367.
"Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis". BMJ345 (oct03 3): e5945. October 2012. doi:10.1136/bmj.e5945. PMC3489107. PMID23038795.
"Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies". The Lancet373 (9672): 1352–63. April 2009. doi:10.1016/S0140-6736(09)60612-7. PMC2670965. PMID19361855.
"Adverse effects of antiretroviral therapy for HIV infection". Canadian Medical Association Journal170 (2): 229–38. January 2004. PMC315530. PMID14734438.
"Influenza vaccination for immunocompromised patients: summary of a systematic review and meta-analysis". Influenza and Other Respiratory Viruses7 Suppl 2: 72–75. September 2013. doi:10.1111/irv.12084. PMC5909396. PMID24034488.
"Complementary and alternative medicine use among HIV-positive people: research synthesis and implications for HIV care". AIDS Care20 (8): 1002–18. September 2008. doi:10.1080/09540120701767216. PMC2570227. PMID18608078.
Antiretroviral Therapy Cohort Collaboration (July 2008). "Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies". The Lancet372 (9635): 293–99. doi:10.1016/S0140-6736(08)61113-7. PMC3130543. PMID18657708.
"The spread, treatment, and prevention of HIV-1: evolution of a global pandemic". The Journal of Clinical Investigation118 (4): 1244–54. April 2008. doi:10.1172/JCI34706. PMC2276790. PMID18382737.
"The origins of acquired immune deficiency syndrome viruses: where and when?". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences356 (1410): 867–76. June 2001. doi:10.1098/rstb.2001.0863. PMC1088480. PMID11405934.
"Serial human passage of simian immunodeficiency virus by unsterile injections and the emergence of epidemic human immunodeficiency virus in Africa". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences356 (1410): 911–20. June 2001. doi:10.1098/rstb.2001.0867. PMC1088484. PMID11405938.
"HIV-related stigma and knowledge in the United States: prevalence and trends, 1991–1999". American Journal of Public Health92 (3): 371–77. March 2002. doi:10.2105/AJPH.92.3.371. PMC1447082. PMID11867313.